Not applicableStudy completedNCT02190123
What this trial is testing
REalWorld Insights on the INitiation and Treatment Duration of ticagrEloR & Other Oral Antiplatelets (OAP) in Patients With Acute Coronary Syndrome (ACS) in Be/Lux.
Who this might be right for
Treatment of Acute Coronary Syndrome (ACS).
AstraZeneca 430